Female preponderance in ibutilide-induced torsade de pointes
Authors:
- 1 June 2004
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 95 (2-3) , 219-222
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Pharmacologic conversion of atrial fibrillation: A systematic review of available evidenceProgress in Cardiovascular Diseases, 2001
- Efficacy and Safety of Ibutilide Fumarate for the Conversion of Atrial Arrhythmias After Cardiac SurgeryCirculation, 1999
- Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillationAmerican Heart Journal, 1998
- Superiority of ibutilide (a new class III agent) overdl-sotalol in converting atrial flutter and atrial fibrillationHeart, 1998
- Electropharmacologic Effects of Class I and Class III Antiarrhythmia Drugs on Typical Atrial FlutterCirculation, 1998
- Conversion Efficacy and Safety of Intravenous Ibutilide Compared With Intravenous Procainamide in Patients With Atrial Flutter or Fibrillation 11This study was sponsored by Pharmacia & Upjohn, Kalamazoo, Michigan.22See Appendix Afor a complete list of investigators and study sites.JACC, 1998
- Safety and Risk/Benefit Analysis of Ibutilide for Acute Conversion of Atrial Fibrillation/FlutterThe American Journal of Cardiology, 1996
- Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or FibrillationCirculation, 1996
- Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response studyJACC, 1996
- Cardioversion of atrial flutter by intravenous ibutilide, a new class III antiarrhythmic agentJACC, 1991